<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">Cdc42 belongs to the Rho subfamily of GTPases, which plays a key role in the initiation and progression of cancer by transmitting oncogenic signals from the cell surface receptors and from activated guanine nucleotide exchange factors (GEF) signaling [
 <xref rid="bib62" ref-type="bibr">62</xref>]. Alternatively, Cdc42 can be activated by the PI3K signaling through activation of PIP3-regulated GEFs, such as P-Rex, Vav, Sos, and SWAP70 [
 <xref rid="bib68" ref-type="bibr">68</xref>]. Recently, Rac1 inhibition has been shown to sensitize pancreatic and breast cancer cells to radiation therapy, therefore, Rac and, similarly, Cdc42 may be regarded as the putative targets for chemosensitization of radiotherapy [
 <xref rid="bib69" ref-type="bibr">69</xref>, 
 <xref rid="bib70" ref-type="bibr">70</xref>, 
 <xref rid="bib71" ref-type="bibr">71</xref>].
</p>
